USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Hemex Inc.
Address:
143 Windsor Ave.
Buffalo, NY 14209
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $134,500.00 3
SBIR Phase II $975,980.00 2

Award List:

ALUMINUM REMOVAL BY CHELATORS IMMOBILIZED IN HOLLOW FIBER

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$45,000.00
Agency:
HHS
Principal Investigator:
Clara M Ambrus Md Phd
Abstract:
N/a

ALUMINUM REMOVAL BY CHELATORS IMMOBILIZED IN HOLLOW FIBER

Award Year / Program / Phase:
1989 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Clara M Ambrus Md Phd
Abstract:
Hemex, inc. has developed a hollow fiber device with immobilized chelators for the extracorporeal removal of toxic metals from blood, specifically aluminum (a1). this device, similar to a hemodialysis cartridge, is a novel approach to detoxification, with unique advantages over existing treatments:… More

BLOOD TISSUE IRON DEPLETION BY EXTRACORPOREAL CHELATOR

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$45,000.00
Agency:
HHS
Principal Investigator:
Ambrus, Clara M , Principal Investigator
Abstract:
The principal aim of this phase i grant is to develop a device with immobilized chelator of clinical capacity, for removal of excess iron from patients with iron overload. we have developed such a device, using polysulfon hollow fiber cartridges with immobilized chelators, for aluminum chelation in… More

IMMOBLIZED CHELATOR FOR EXTRACORPOREAL LEAD REMOVAL

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$44,500.00
Agency:
HHS
Principal Investigator:
, Principal Investigator
Abstract:
N/a

IMMOBLIZED CHELATOR FOR EXTRACORPOREAL LEAD REMOVAL

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$475,980.00
Agency:
HHS
Principal Investigator:
, Principal Investigator
Abstract:
Recent reports estimate the number of children with lead intoxication at 230,000, the number of industrial workers with lead poisoning at 530,000. these number create a medical problem of alarming magnitude, because treatment with available chelators has serious side-effects. even the chelator-lead… More